JP6602765B2 - クロマトグラフィー再使用のための方法 - Google Patents

クロマトグラフィー再使用のための方法 Download PDF

Info

Publication number
JP6602765B2
JP6602765B2 JP2016540425A JP2016540425A JP6602765B2 JP 6602765 B2 JP6602765 B2 JP 6602765B2 JP 2016540425 A JP2016540425 A JP 2016540425A JP 2016540425 A JP2016540425 A JP 2016540425A JP 6602765 B2 JP6602765 B2 JP 6602765B2
Authority
JP
Japan
Prior art keywords
antibody
protein
polypeptide
buffer
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016540425A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016530533A5 (enExample
JP2016530533A (ja
Inventor
エクタ マハジャン，
カピル コタリー，
ジョアンナ ソ，
ジェイ ワーバー，
Original Assignee
ジェネンテック， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェネンテック， インコーポレイテッド filed Critical ジェネンテック， インコーポレイテッド
Publication of JP2016530533A publication Critical patent/JP2016530533A/ja
Publication of JP2016530533A5 publication Critical patent/JP2016530533A5/ja
Application granted granted Critical
Publication of JP6602765B2 publication Critical patent/JP6602765B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B01D15/203—Equilibration or regeneration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/60—Cleaning or rinsing ion-exchange beds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2016540425A 2013-09-05 2014-09-05 クロマトグラフィー再使用のための方法 Active JP6602765B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361874305P 2013-09-05 2013-09-05
US61/874,305 2013-09-05
PCT/US2014/054313 WO2015035180A1 (en) 2013-09-05 2014-09-05 Method for chromatography reuse

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018242197A Division JP2019094334A (ja) 2013-09-05 2018-12-26 クロマトグラフィー再使用のための方法

Publications (3)

Publication Number Publication Date
JP2016530533A JP2016530533A (ja) 2016-09-29
JP2016530533A5 JP2016530533A5 (enExample) 2017-10-19
JP6602765B2 true JP6602765B2 (ja) 2019-11-06

Family

ID=52628962

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016540425A Active JP6602765B2 (ja) 2013-09-05 2014-09-05 クロマトグラフィー再使用のための方法
JP2018242197A Withdrawn JP2019094334A (ja) 2013-09-05 2018-12-26 クロマトグラフィー再使用のための方法
JP2021088108A Withdrawn JP2021155421A (ja) 2013-09-05 2021-05-26 クロマトグラフィー再使用のための方法
JP2023035358A Pending JP2023085273A (ja) 2013-09-05 2023-03-08 クロマトグラフィー再使用のための方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018242197A Withdrawn JP2019094334A (ja) 2013-09-05 2018-12-26 クロマトグラフィー再使用のための方法
JP2021088108A Withdrawn JP2021155421A (ja) 2013-09-05 2021-05-26 クロマトグラフィー再使用のための方法
JP2023035358A Pending JP2023085273A (ja) 2013-09-05 2023-03-08 クロマトグラフィー再使用のための方法

Country Status (9)

Country Link
US (2) US20150093800A1 (enExample)
EP (1) EP3041593B1 (enExample)
JP (4) JP6602765B2 (enExample)
KR (1) KR20160050062A (enExample)
CN (1) CN105848746B (enExample)
CA (1) CA2922832A1 (enExample)
MX (1) MX2016002798A (enExample)
RU (1) RU2016112549A (enExample)
WO (1) WO2015035180A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3041857B1 (en) * 2013-09-04 2019-05-08 EMD Millipore Corporation Protein a chromatography
CN106460027B (zh) * 2014-03-24 2020-07-31 日东纺绩株式会社 使用阳离子性接枝聚合物的目标物分离浓缩方法
US10550148B2 (en) 2014-06-16 2020-02-04 Emd Millipore Corporation Methods for increasing the capacity of flow-through processes
WO2015195452A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Single-pass filtration systems and processes
SG11201508171RA (en) 2014-06-25 2016-01-28 Emd Millipore Corp Compact spiral-wound filter elements, modules and systems
US10350518B2 (en) 2014-08-29 2019-07-16 Emd Millipore Corporation Processes for filtering liquids using single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
KR102188947B1 (ko) 2014-08-29 2020-12-09 이엠디 밀리포어 코포레이션 잔류물의 재순환을 이용한 싱글 패스 접선 유동 여과 시스템 및 접선 유동 여과 시스템
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
EP3455243B1 (en) 2016-05-11 2021-03-24 Cytiva BioProcess R&D AB Separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
EP4066927B1 (en) 2016-06-09 2024-10-09 EMD Millipore Corporation Methods of using radial-path filter elements
KR102369014B1 (ko) 2016-08-16 2022-03-02 리제너론 파아마슈티컬스, 인크. 혼합물로부터 개별 항체들을 정량하는 방법
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
ES3032778T3 (en) 2016-10-25 2025-07-24 Regeneron Pharma Methods for chromatography data analysis
CN110267721B (zh) * 2017-01-30 2022-03-01 瑞泽恩制药公司 用于降低色谱中生物负载的组合物和方法
MY203415A (en) 2017-09-19 2024-06-27 Regeneron Pharma Methods of reducing particle formation and compositions formed thereby
TW202448568A (zh) 2018-07-02 2024-12-16 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
KR20210148349A (ko) * 2019-04-17 2021-12-07 브리스톨-마이어스 스큅 컴퍼니 크로마토그래피 수지의 재생 방법
CN110075569B (zh) * 2019-05-07 2021-04-23 世瑞纳科(北京)科技有限责任公司 糖化血红蛋白分析仪高效液相色谱柱的再生方法
AR119264A1 (es) * 2019-06-05 2021-12-09 Genentech Inc Método para reutilización de cromatografía
MA56197A (fr) * 2019-06-13 2022-04-20 Regeneron Pharma Procédés d'élimination de composants indésirables pendant des processus chromatographiques en plusieurs étapes
CN120334439A (zh) * 2019-09-24 2025-07-18 里珍纳龙药品有限公司 用于色谱介质的使用和再生的系统及方法
EP3862078A1 (de) * 2020-02-05 2021-08-11 Pentracor GmbH Verwendung einer alkalihydroxid-lösung zur regeneration einer apheresesäule
CN112843789A (zh) * 2020-12-29 2021-05-28 上海赛梵科分离技术有限公司 大麻二酚纯化中色谱填料和层析介质的再生方法
CN112646045A (zh) * 2021-01-06 2021-04-13 海默斯（重庆）医学生物技术有限公司 一种重组角蛋白分离纯化方法
JP2024518400A (ja) * 2021-05-07 2024-05-01 ジェンザイム・コーポレーション 衛生化のための組成物および方法
CN113842673B (zh) * 2021-09-07 2023-01-06 济宁海关综合技术服务中心 液相色谱柱再生方法
TW202337900A (zh) * 2022-01-12 2023-10-01 美商再生元醫藥公司 改良使用親和層析的異二聚蛋白質自雜質之解析的方法
WO2024137698A1 (en) * 2022-12-19 2024-06-27 Eli Lilly And Company Methods of cleaning chromatography matrices

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
DE3850542T2 (de) 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ATE144793T1 (de) 1989-06-29 1996-11-15 Medarex Inc Bispezifische reagenzien für die aids-therapie
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
ATE419355T1 (de) 1992-02-06 2009-01-15 Novartis Vaccines & Diagnostic Marker für krebs und biosynthetisches bindeprotein dafür
EP0626012B1 (en) 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
ATE149570T1 (de) 1992-08-17 1997-03-15 Genentech Inc Bispezifische immunoadhesine
ES2091684T3 (es) 1992-11-13 1996-11-01 Idec Pharma Corp Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b.
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
US6866844B2 (en) 2002-11-07 2005-03-15 Biomarin Pharmaceutical Inc. Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
US8372954B2 (en) 2000-12-22 2013-02-12 National Research Council Of Canada Phage display libraries of human VH fragments
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
CN1771080B (zh) * 2003-04-08 2010-12-15 诺沃挪第克公司 包括至少一个色谱处理步骤的生产治疗用多肽或其前体的方法
DK1613409T3 (da) 2003-04-08 2019-09-30 Novo Nordisk As Regenerering af kromatografiske stationære faser
DK1639011T3 (da) 2003-06-30 2009-02-16 Domantis Ltd Pegylerede enkelt-domæne antistoffer (dAb)
PL3095793T3 (pl) 2003-07-28 2020-09-07 Genentech, Inc. Redukcja wycieku białka A w trakcie chromatografii powinowactwa z białkiem A
EP1506809A1 (en) * 2003-08-11 2005-02-16 Boehringer Ingelheim Pharma GmbH & Co. KG Regeneration of hydrolysis sensitive adsorbent matrices
WO2006031370A2 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
ES2579805T3 (es) 2004-09-23 2016-08-16 Genentech, Inc. Anticuerpos y conjugados modificados por ingeniería genética con cisteína
JP2008535913A (ja) * 2005-04-11 2008-09-04 メダレックス インコーポレーティッド タンパク質精製方法
JP5148484B2 (ja) * 2005-05-24 2013-02-20 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ クロマトグラフィーマトリックスの再生
US20070093399A1 (en) * 2005-10-26 2007-04-26 Selective Micro Technologies, Llc Cleaning, sanitization and regeneration of chromatography media using chlorine dioxide
JP5361738B2 (ja) * 2007-01-22 2013-12-04 ジェネンテック， インコーポレイテッド 多価電解質沈殿物及びタンパク質の精製
US20120282654A1 (en) * 2009-04-29 2012-11-08 Schering Corporation Antibody purification
CN102574911B (zh) * 2009-08-07 2017-06-06 Emd密理博公司 从样品的一或多种杂质中纯化靶蛋白的方法
JP5909450B2 (ja) * 2009-12-18 2016-04-26 ノバルティス アーゲー 洗浄溶液及びアフィニティークロマトグラフィーの方法
JP5550109B2 (ja) * 2010-04-26 2014-07-16 独立行政法人産業技術総合研究所 溶液中のイムノグロブリン量の測定方法
KR101152036B1 (ko) * 2010-04-27 2012-06-08 (주)셀트리온 컬럼 순환 및 시료 연속주입법을 이용한 단백질 ａ 크로마토그래피 정제 방법
CN101838215B (zh) * 2010-05-25 2013-03-27 刘伟斌 一种dmac恒沸物中分离乙酸的工艺
MY161534A (en) 2010-05-25 2017-04-28 Genentech Inc Methods of purifying polypeptides
CN101914433A (zh) * 2010-08-26 2010-12-15 华中科技大学 发酵与扩张床原位吸附耦合的乳酸生产工艺
CN107915769A (zh) * 2011-03-29 2018-04-17 葛兰素史密斯克莱有限责任公司 用于蛋白纯化的缓冲液体系
EP2511293A1 (en) * 2011-04-13 2012-10-17 LEK Pharmaceuticals d.d. A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
SG11201400236YA (en) * 2011-09-01 2014-03-28 Human Genome Sciences Inc Viral clearance methods
WO2013176754A1 (en) * 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
EP3041857B1 (en) * 2013-09-04 2019-05-08 EMD Millipore Corporation Protein a chromatography

Also Published As

Publication number Publication date
CN105848746B (zh) 2019-07-09
US20190054396A1 (en) 2019-02-21
US20150093800A1 (en) 2015-04-02
US10940401B2 (en) 2021-03-09
RU2016112549A (ru) 2017-10-10
JP2021155421A (ja) 2021-10-07
MX2016002798A (es) 2016-07-21
JP2016530533A (ja) 2016-09-29
EP3041593B1 (en) 2025-01-29
CA2922832A1 (en) 2015-03-12
WO2015035180A1 (en) 2015-03-12
EP3041593A1 (en) 2016-07-13
KR20160050062A (ko) 2016-05-10
CN105848746A (zh) 2016-08-10
JP2019094334A (ja) 2019-06-20
JP2023085273A (ja) 2023-06-20
EP3041593A4 (en) 2017-08-30
EP3041593C0 (en) 2025-01-29

Similar Documents

Publication Publication Date Title
JP6602765B2 (ja) クロマトグラフィー再使用のための方法
JP7203928B2 (ja) オーバーロード／溶出クロマトグラフィー
US20220203347A1 (en) Method for regeneration of an overload chromatography column
JP2025186245A (ja) クロマトグラフィー再使用のための方法
EP3527274B1 (en) Overload and elute chromatography
HK1240254B (zh) 超载和洗脱层析
HK1227797B (zh) 用於层析重复利用的方法
HK1227797A1 (en) Method for chromatography reuse
NZ624317B2 (en) Overload and elute chromatography

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170905

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180613

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180626

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180925

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190801

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190910

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191009

R150 Certificate of patent or registration of utility model

Ref document number: 6602765

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250